BRIEF published on 01/14/2025 at 17:08, 1 year 6 months ago Eckert & Ziegler s'associe à une joint-venture chinoise pour la production d'actinium 225 Essais Cliniques Produits Radiopharmaceutiques Contrat De Licence Actinium 225 Expansion De L'offre
PRESS RELEASE published on 01/14/2025 at 17:03, 1 year 6 months ago EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE signs licence agreement with Chinese joint venture for Ac-225 cyclotron technology, aiming to increase supply of Ac-225 for radiopharmaceutical industry Radiopharmaceutical Industry Eckert & Ziegler SE Licence Agreement Ac-225 Chinese Joint Venture
BRIEF published on 01/13/2025 at 10:05, 1 year 6 months ago Eckert & Ziegler and GlyTherix Expand Collaboration with Actinium-225 Supply Agreement Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Actinium-225 GlyTherix
BRIEF published on 01/13/2025 at 10:05, 1 year 6 months ago Eckert & Ziegler et GlyTherix étendent leur collaboration avec un accord de fourniture d'actinium-225 Eckert & Ziegler Produits Radiopharmaceutiques Thérapie Contre Le Cancer GlyTherix Actinium 225
PRESS RELEASE published on 01/13/2025 at 10:00, 1 year 6 months ago Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement Eckert & Ziegler and GlyTherix extend collaboration with Actinium-225 supply agreement, enhancing cancer therapy access globally Eckert & Ziegler Collaboration Actinium-225 GlyTherix Radiotherapy
BRIEF published on 12/13/2024 at 09:05, 1 year 7 months ago Eckert & Ziegler Seeks Approval for GalliaPharm® in Japan Diagnostic Imaging Regulatory Approval Nuclear Medicine Japanese Market GalliaPharm®
BRIEF published on 12/13/2024 at 09:05, 1 year 7 months ago Eckert & Ziegler demande l'approbation de GalliaPharm® au Japon Marché Japonais Approbation Réglementaire Médecine Nucléaire GalliaPharm® Imagerie Diagnostique
PRESS RELEASE published on 12/13/2024 at 09:00, 1 year 7 months ago Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW Eckert & Ziegler submits GalliaPharm for approval in Japan, expanding access to advanced diagnostic tools like 68Ga-PSMA-11, enhancing precision in oncology imaging Oncology Eckert & Ziegler Diagnostic Imaging Japan Approval GalliaPharm
BRIEF published on 12/05/2024 at 09:35, 1 year 8 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement Cancer Treatment Precision Medicine Radiopharmaceuticals Supply Agreement Isotopes
BRIEF published on 12/05/2024 at 09:35, 1 year 8 months ago Eckert & Ziegler et Ariceum Therapeutics signent un accord d'approvisionnement mondial Traitement Du Cancer Produits Radiopharmaceutiques Médecine De Précision Contrat De Fourniture Isotopes
Published on 08/10/2026 at 11:00, 18 minutes ago Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners
Published on 08/10/2026 at 08:00, 3 hours 18 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 3 hours 18 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 12 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/10/2026 at 10:12, 1 hour 5 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 1 hour 7 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 1 hour 28 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 2 hours 17 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:47, 1 hour 30 minutes ago 260810 BENETEAU Transactions sur actions propres
Published on 08/10/2026 at 09:22, 1 hour 55 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 55 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 4 hours 18 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 4 hours 18 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
